DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Paz-Ares L, Dvorkin M, Chen Y. et al; CASPIAN investigators.
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Lancet 2019;
394 (10212): 1929-1939
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.